Insider · CIK 0002040256
Mert Aktar
Files at KYTX (Kyverna Therapeutics, Inc.). First filing -, latest -.
In brief
Mert Aktar files SEC Form 4 as director at KYTX (Kyverna Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Mert Aktar has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 27, 2026 | KYTX Kyverna Therapeutics, Inc. | AGrant or award Common Stock | +5,093 | $0.00 | $0 | 21,727 | May 29, 2026 |
| May 27, 2026 | KYTX Kyverna Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +20,582 | $0.00 | $0 | 20,582 | May 29, 2026 |
| May 29, 2025 | KYTX Kyverna Therapeutics, Inc. | AGrant or award Common Stock | +16,634 | $0.00 | $0 | 16,634 | Jun 2, 2025 |
| May 29, 2025 | KYTX Kyverna Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +65,351 | $0.00 | $0 | 65,351 | Jun 2, 2025 |
| Oct 21, 2024 | KYTX Kyverna Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +87,741 | $0.00 | $0 | 87,741 | Oct 24, 2024 |
Questions about Mert Aktar
Answered from the filings on this page, as of the latest one.
Is Mert Aktar buying or selling?
Mert Aktar has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Mert Aktar's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mert Aktar has 0.
Where does Mert Aktar file Form 4?
Mert Aktar has filed Form 4 at KYTX (Kyverna Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.